These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 24667935)
1. Capillary morphogenesis gene 2 inhibits growth of breast cancer cells and is inversely correlated with the disease progression and prognosis. Ye L; Sun PH; Malik MF; Mason MD; Jiang WG J Cancer Res Clin Oncol; 2014 Jun; 140(6):957-67. PubMed ID: 24667935 [TBL] [Abstract][Full Text] [Related]
2. P14ARF is down-regulated during tumour progression and predicts the clinical outcome in human breast cancer. Wazir U; Jiang WG; Yasaei H; Linne H; Newbold RF; Mokbel K Anticancer Res; 2013 May; 33(5):2185-9. PubMed ID: 23645774 [TBL] [Abstract][Full Text] [Related]
3. The mRNA expression of inhibitors of DNA binding-1 and -2 is associated with advanced tumour stage and adverse clinical outcome in human breast cancer. Wazir U; Jiang WG; Sharma AK; Newbold RF; Mokbel K Anticancer Res; 2013 May; 33(5):2179-83. PubMed ID: 23645773 [TBL] [Abstract][Full Text] [Related]
4. Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer. Zhi X; Wang Y; Yu J; Yu J; Zhang L; Yin L; Zhou P IUBMB Life; 2012 Nov; 64(11):911-20. PubMed ID: 23086814 [TBL] [Abstract][Full Text] [Related]
5. Nucleobindin 2 in human breast carcinoma as a potent prognostic factor. Suzuki S; Takagi K; Miki Y; Onodera Y; Akahira J; Ebata A; Ishida T; Watanabe M; Sasano H; Suzuki T Cancer Sci; 2012 Jan; 103(1):136-43. PubMed ID: 21988594 [TBL] [Abstract][Full Text] [Related]
6. JAM-A expression positively correlates with poor prognosis in breast cancer patients. McSherry EA; McGee SF; Jirstrom K; Doyle EM; Brennan DJ; Landberg G; Dervan PA; Hopkins AM; Gallagher WM Int J Cancer; 2009 Sep; 125(6):1343-51. PubMed ID: 19533747 [TBL] [Abstract][Full Text] [Related]
7. The impact of angio-associated migratory cell protein (AAMP) on breast cancer cells in vitro and its clinical significance. Yin Y; Sanders AJ; Jiang WG Anticancer Res; 2013 Apr; 33(4):1499-509. PubMed ID: 23564791 [TBL] [Abstract][Full Text] [Related]
8. Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer. Grönberg M; Fjällskog ML; Jirström K; Janson ET Acta Oncol; 2012 Mar; 51(3):386-93. PubMed ID: 22067021 [TBL] [Abstract][Full Text] [Related]
9. High expression and prognostic role of CAP1 and CtBP2 in breast carcinoma: associated with E-cadherin and cell proliferation. Liu X; Yao N; Qian J; Huang H Med Oncol; 2014 Mar; 31(3):878. PubMed ID: 24522810 [TBL] [Abstract][Full Text] [Related]
10. HYAL1 overexpression is correlated with the malignant behavior of human breast cancer. Tan JX; Wang XY; Li HY; Su XL; Wang L; Ran L; Zheng K; Ren GS Int J Cancer; 2011 Mar; 128(6):1303-15. PubMed ID: 20473947 [TBL] [Abstract][Full Text] [Related]
11. Relationship between IL-10 expression and prognosis in patients with primary breast cancer. Li Y; Gao P; Yang J; Yu H; Zhu Y; Si W Tumour Biol; 2014 Nov; 35(11):11533-40. PubMed ID: 25129439 [TBL] [Abstract][Full Text] [Related]
12. Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer. Lanigan F; McKiernan E; Brennan DJ; Hegarty S; Millikan RC; McBryan J; Jirstrom K; Landberg G; Martin F; Duffy MJ; Gallagher WM Int J Cancer; 2009 May; 124(9):2088-97. PubMed ID: 19142967 [TBL] [Abstract][Full Text] [Related]
13. High TIMM17A expression is associated with adverse pathological and clinical outcomes in human breast cancer. Salhab M; Patani N; Jiang W; Mokbel K Breast Cancer; 2012 Apr; 19(2):153-60. PubMed ID: 20972741 [TBL] [Abstract][Full Text] [Related]
14. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer. Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of capillary morphogenesis gene 2 extracellular vWA domain in tumour‑related angiogenesis. Ye L; Sun PH; Sanders AJ; Martin TA; Lane J; Mason MD; Jiang WG Int J Oncol; 2014 Oct; 45(4):1565-73. PubMed ID: 24993339 [TBL] [Abstract][Full Text] [Related]
16. Local expression of complement factor I in breast cancer cells correlates with poor survival and recurrence. Okroj M; Holmquist E; Nilsson E; Anagnostaki L; Jirström K; Blom AM Cancer Immunol Immunother; 2015 Apr; 64(4):467-78. PubMed ID: 25618258 [TBL] [Abstract][Full Text] [Related]
17. Effects of differential distribution of microvessel density, possibly regulated by miR-374a, on breast cancer prognosis. Li JY; Zhang Y; Zhang WH; Jia S; Kang Y; Tian R Asian Pac J Cancer Prev; 2013; 14(3):1715-20. PubMed ID: 23679262 [TBL] [Abstract][Full Text] [Related]
18. Expression of aquaporin1, a water channel protein, in cytoplasm is negatively correlated with prognosis of breast cancer patients. Qin F; Zhang H; Shao Y; Liu X; Yang L; Huang Y; Fu L; Gu F; Ma Y Oncotarget; 2016 Feb; 7(7):8143-54. PubMed ID: 26812884 [TBL] [Abstract][Full Text] [Related]
19. Anthrax toxin receptor 2 is expressed in murine and tumor vasculature and functions in endothelial proliferation and morphogenesis. Reeves CV; Dufraine J; Young JA; Kitajewski J Oncogene; 2010 Feb; 29(6):789-801. PubMed ID: 19901963 [TBL] [Abstract][Full Text] [Related]
20. Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer. Fu DY; Tan HS; Wei JL; Zhu CR; Jiang JX; Zhu YX; Cai FL; Chong MH; Ren CL Tumour Biol; 2015 Sep; 36(10):8025-34. PubMed ID: 25971583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]